Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Pierre Moffatt
Introduction: Pierre Moffatt, an esteemed inventor based in Lachine, Canada, has made significant contributions to the field of biotechnology. With two patents to his name, Moffatt has demonstrated a commitment to pioneering research and innovation that can have lasting impacts on medical science.
Latest Patents: Moffatt's latest patents reflect his focus on enhancing osteogenesis and renal function through innovative methods. His first patent details a method for using specific natriuretic peptide receptor C ligands and their respective antagonists in transgenic non-human mammals. This method involves administering a therapeutically effective amount of an osteocrin or NPR-C specific osteocrin peptide derivative to increase bone formation in mammals.
The second patent focuses on "Bone Polypeptide-1," a novel polypeptide and its encoding nucleic acid molecules. This invention provides the human primary sequence for Bone Polypeptide-1, along with sequences for vertebrate homologs. Moffatt’s work includes engineered cell lines that express the cDNA, antibodies for detection, and recombinant adenoviruses for cDNA delivery, aiming to treat diseases that affect renal and bone functions.
Career Highlights: Pierre Moffatt is currently associated with Enobia Pharma Inc., a company known for its dedication to developing innovative therapies. His career has been marked by a willingness to push the boundaries of scientific understanding and to seek solutions for complex medical challenges.
Collaborations: Throughout his career, Moffatt has collaborated with notable coworkers such as Christian Lanctot and Gethin Thomas. Together, they have worked on advancing shared goals within the realm of biopharmaceuticals, contributing to breakthroughs that benefit patients and the wider medical community.
Conclusion: Pierre Moffatt's innovative spirit and dedication to research have positioned him as a noteworthy inventor within the biotechnology sector. Through his patents and collaborations, he continues to positively impact medical science, paving the way for future discoveries that can improve health outcomes.